I.CENTURY HLDG (08507) plans to carry out a rights issue on a basis of "1 offer for 1 share", netting approximately HKD 39.6 million.
Century Group (08507) announced that the board of directors has proposed to issue 1 share for every 1 share held on the record date, at a subscription price of HK$0.10 per share, to raise approximately HK$40 million (assuming no further issuance or repurchase of shares before or on the record date) through offering up to 400 million shares for subscription to eligible shareholders.
I.CENTURY HLDG (08507) announces that the board of directors recommends (including) a rights issue of 1 rights share for every 1 share held as at the record date at a subscription price of HK$0.10 per rights share. The rights issue will involve offering up to a maximum of 400 million rights shares to eligible shareholders to raise a total amount of approximately HK$40 million (assuming no further issuance or repurchase of shares before or on the record date).
Assuming full subscription, after deducting all necessary expenses, the net proceeds from the rights issue are estimated to be approximately HK$39.6 million, intended for the following purposes: (i) approximately HK$23.6 million will be allocated for the group's general operational expenses, including director's fees, employee salaries and benefits (including but not limited to salaries, bonuses, allowances, retirement benefit plan contributions), rent and property management fees, professional service fees, and other business and corporate expenses; (ii) approximately HK$6 million will be used to repay certain loans of the group; (iii) approximately HK$10 million will be used to enhance the group's existing supply chain management (SCM) services through process and operational optimization, with the aim of strengthening the group's capabilities in product development, procurement, production management, quality control, and logistics management. These enhancement measures will utilize artificial intelligence, integrate Internet of Things (IoT) technology for real-time inventory tracking, and apply intelligent algorithm-driven route optimization to support more accurate decision-making and dynamic responsiveness, thus improving supply chain transparency and shortening response times.
Related Articles

CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.

CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.

Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.
CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.

CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.

Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.

RECOMMEND

“Memory Price Surge” For 100 Days, Low‑End Smartphones Forced Into Decline
19/03/2026

Hong Kong Suddenly Becomes A New Destination For Middle Eastern Capital? Signs Of Increased Allocation Are Evident
19/03/2026

Memory Price Surge Persists For 100 Days, Forcing Low‑End Smartphones Toward Extinction
19/03/2026


